NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NBI NASDAQ Biotechnology

Closed 04-16 16:00:00 EDT

6,035.09

-42.64

-0.70%

High6,077.57	Low6,008.64	Vol0.00
Open6,065.18	D1 Closing6,077.73	Amplitude1.13%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O--	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NBI","market":"US","secType":"STK","nameCN":"NASDAQ Biotechnology","latestPrice":6035.0854,"timestamp":1776369600000,"preClose":6077.7256,"halted":0,"volume":0,"delay":0,"changeRate":-0.0070158152582603965,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-42.6402,"latestTime":"04-16 16:00:00 EDT","open":6065.182,"high":6077.5684,"low":6008.6357,"amount":0,"amplitude":0.011342,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":5,"adr":0,"adjPreClose":6077.7256,"symbolType":"index"},"requestUrl":"/m/hq/s/NBI/wiki","defaultTab":"wiki","newsList":[{"id":"2627182112","title":"Press Release: National Bank Investments announces NBI ETFs and ETF Series of NBI Funds cash distributions for April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627182112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627182112?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:30","pubTimestamp":1776342600,"startTime":"0","endTime":"0","summary":"Unitholders of record on April 23, 2026 will receive cash distributions on April 30, 2026, as follows:. NBI Global Real Assets Income Fund - ETF    NREA     $0.0300        Monthly. NBI Active Canadian Preferred Shares ETF    NPRF     $0.1000        Monthly. NBI Unconstrained Fixed Income ETF          NUBF     $0.0700        Monthly. NBI Sustainable Canadian Bond ETF           NSCB     $0.0600        Monthly. NBI Canadian Dividend Income ETF            NDIV     $0.0700        Monthly. NBI Sustainable Canadian Short Term Bond    NSSB     $0.0260        Monthly. NBI Target 2026 Investment Grade Bond Fund  NTGA     $0.0090        Monthly. NBI Target 2027 Investment Grade Bond Fund  NTGB     $0.0120        Monthly. NBI Target 2028 Investment Grade Bond Fund  NTGC     $0.0160        Monthly. Guided by an open architecture strategy, NBI is dedicated to providing diverse solutions to meet the evolving needs of its clients.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4588","US7Y.BOND","US3Y.BOND","LU0310799852.SGD","LU0052756011.USD","LU0211328371.USD","US2Y.BOND","BK4585","TGT","LU0823411888.USD","US30Y.BOND","BK4114","NBHC","BK4211","NBI","BK4596","LU0128525689.USD","LU1244550494.USD","US5Y.BOND","BK4155","LU2237443382.USD","BK4532","TMF","BK4504","LU1244550221.USD","LU0310800965.SGD","TLT","LU2237443978.SGD","LU1244550577.SGD","US12M.BOND","US10Y.BOND","BK4550","FDN","LU0211327993.USD","TLTW","BK4597","LU1267930227.SGD","LU2237443549.SGD","US6M.BOND","LU2237443622.USD","LU1267930490.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620073424","title":"Press Release: National Bank Investments announces NBI ETFs and ETF Series of NBI Funds cash distributions for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620073424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620073424?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:30","pubTimestamp":1773750600,"startTime":"0","endTime":"0","summary":"Unitholders of record on March 24, 2026 will receive cash distributions on March 31, 2026, as follows:. NBI Global Real Assets Income Fund - ETF    NREA     $0.0350        Monthly. NBI Active Canadian Preferred Shares ETF    NPRF     $0.1000        Monthly. NBI Unconstrained Fixed Income ETF          NUBF     $0.0700        Monthly. NBI Sustainable Canadian Bond ETF           NSCB     $0.0550        Monthly. NBI Target 2026 Investment Grade Bond Fund  NTGA     $0.0120        Monthly. NBI Target 2027 Investment Grade Bond Fund  NTGB     $0.0150        Monthly. NBI ETFs and ETF Series of NBI Funds are offered by NBI, an indirect wholly owned subsidiary of National Bank of Canada and sold by authorized dealers. Management fees, brokerage fees and expenses all may be associated with investments in NBI ETFs or ETF Series of NBI Funds. Please read the simplified prospectus or ETF Facts documents before investing. NBI ETFs and ETF Series of NBI Funds are not guaranteed, their values change fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMF","BK4504","LU0823411888.USD","BK4597","BK4114","LU1244550577.SGD","LU1267930490.SGD","BK4155","LU0211328371.USD","BK4585","LU2237443622.USD","LU2237443382.USD","LU0211327993.USD","NBHC","BK4211","LU1267930227.SGD","US3Y.BOND","US2Y.BOND","US30Y.BOND","TGT","LU0128525689.USD","US6M.BOND","LU0052756011.USD","BK4532","BK4596","LU2237443549.SGD","BK4533","US12M.BOND","US5Y.BOND","LU0310799852.SGD","BK4550","LU2237443978.SGD","FDN","BK4588","US10Y.BOND","LU0310800965.SGD","LU1244550221.USD","US7Y.BOND","TLTW","LU1244550494.USD","NBI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603838999","title":"Press Release: National Bank Investments Announces January 2026 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2603838999","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603838999?lang=en_us&edition=fundamental","pubTime":"2026-01-16 21:30","pubTimestamp":1768570200,"startTime":"0","endTime":"0","summary":"Unitholders of record on January 23, 2026, will receive cash distributions on January 30, 2026, as detailed in the table below.NBI Global Real Assets Income Fund - ETF      NREA    $0.0400       Monthly. NBI Active Canadian Preferred Shares ETF      NPRF    $0.1000       Monthly. NBI Sustainable Canadian Bond ETF             NSCB    $0.0600       Monthly. NBI Sustainable Canadian Corporate Bond ETF   NSCC    $0.0600       Monthly. NBI Sustainable Canadian Short Term Bond ETF  NSSB    $0.0260       Monthly. NBI Target 2026 Investment Grade Bond Fund -  NTGA    $0.0160       Monthly. NBI Target 2027 Investment Grade Bond Fund -  NTGB    $0.0120       Monthly. NBI is an investment funds management firm committed to manufacturing and offering mutual funds, investment solutions and services designed to help Canadian investors pursue their financial goals. As at December 31, 2025, assets under management in NBI products were valued at over $109 billion.Guided by an open architecture strategy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBHC","BK4550","LU2237443978.SGD","BK4211","LU0823411888.USD","BK4585","TLTW","BK4597","US12M.BOND","BK4588","NBI","BK4155","LU0128525689.USD","BK4532","US10Y.BOND","US2Y.BOND","LU0310799852.SGD","BK4504","LU2237443622.USD","FDN","LU1244550577.SGD","LU1267930490.SGD","LU1267930227.SGD","TMF","LU0211328371.USD","LU1244550494.USD","US6M.BOND","BK4533","TGT","US5Y.BOND","LU2237443549.SGD","LU0310800965.SGD","US7Y.BOND","LU0052756011.USD","LU1244550221.USD","BK4114","US30Y.BOND","LU2237443382.USD","LU0211327993.USD","BK4596","US3Y.BOND"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601822881","title":"Press Release: National Bank Investments Announces Revised 2025 Annual Reinvested Distribution Amounts for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2601822881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601822881?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:00","pubTimestamp":1767618000,"startTime":"0","endTime":"0","summary":"The following is a list of NBI ETFs and NBI ETF Series and the revised amounts of per-unit reinvested distributions:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4155","LU0211328371.USD","LU0310800965.SGD","FDN","BK4211","BK4532","TGT","US3Y.BOND","US10Y.BOND","LU1267930490.SGD","LU1244550494.USD","NBI","TLTW","US2Y.BOND","US6M.BOND","LU0310799852.SGD","LU1244550577.SGD","LU1267930227.SGD","LU0052756011.USD","LU2237443978.SGD","BK4550","LU1244550221.USD","BK4533","BK4596","US30Y.BOND","US7Y.BOND","US5Y.BOND","TMF","LU0211327993.USD","US12M.BOND","LU2237443382.USD","BK4114","LU2237443622.USD","BK4588","BK4504","LU2237443549.SGD","LU0823411888.USD","BK4597","LU0128525689.USD","NBHC","BK4585"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2593941230","title":"Upstream Bio (UPB): Reassessing Valuation After NASDAQ Biotechnology Index Inclusion and Sharp 3‑Month Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2593941230","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593941230?lang=en_us&edition=fundamental","pubTime":"2025-12-23 22:15","pubTimestamp":1766499309,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) just earned a spot in the NASDAQ Biotechnology Index, a visibility upgrade that can quietly reshape its investor base, trading volume, and how the market values its pipeline.\nSee our latest analysis for Upstream Bio.\nThat index inclusion lands on top of already strong momentum, with the share price at $30.43 and an 86.92% 3 month share price return that suggests investors are re-rating its risk and growth profile rather than just reacting to a one day move.\nIf this kind of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-upb/upstream-bio/news/upstream-bio-upb-reassessing-valuation-after-nasdaq-biotechn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-upb/upstream-bio/news/upstream-bio-upb-reassessing-valuation-after-nasdaq-biotechn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["QID","NQmain","QLD","BK4139","TQQQ","TSYW.SI","MNQmain","NVIW.SI","NBI","SQQQ","UPB",".IXIC","PSQ","USAW.SI","USJW.SI"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2592096359","title":"Press Release: National Bank Investments Announces December 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2592096359","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592096359?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:30","pubTimestamp":1766064600,"startTime":"0","endTime":"0","summary":"Unitholders of record on December 30, 2025, will receive cash distributions on January 7, 2026, as detailed in the table below.ETF or ETF Series name          Ticker symbol  Cash           Paymentfrequency. NBI Global Real Assets Income   NREA           $0.010396      Monthly. NBI High Yield Bond ETF         NHYB           $0.111633      Monthly. NBI Global Private Equity ETF   NGPE           $0.832270      Annual. NBI Active U.S. Equity ETF      NUSA           -              Quarterly. NBI Active U.S. Equity ETF -    NUSA.F         -              Quarterly. NBI Canadian Core Plus Bond     NCPB           -              Monthly. NBI Innovators Fund - ETF       NINV           -              Annual. NBI Innovators Fund - ETFH      NINV.F         -              Annual. NBI Quebec Growth Fund - ETF    NBQC           -              Annual. NBI U.S. Equity Fund - ETF      NBUE           -              Annual. NBI U.S. Equity Fund - ETFH     NBUE.F         -              Annual. NBI Global Equ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","BK4155","TLTW","BK4585","FDN","US10Y.BOND","US2Y.BOND","BK4596","NBI","BK4504","NBHC","LU1244550221.USD","LU1244550577.SGD","TGT","BK4533","US30Y.BOND","BK4588","BK4114","BK4211","LU1267930227.SGD","LU0823411888.USD","US5Y.BOND","LU0211328371.USD","TMF","LU2237443382.USD","LU0052756011.USD","US3Y.BOND","BK4532","LU1267930490.SGD","LU2237443622.USD","BK4550","LU0310800965.SGD","US7Y.BOND","LU0128525689.USD","LU2237443978.SGD","US6M.BOND","LU1244550494.USD","US12M.BOND","LU2237443549.SGD","LU0310799852.SGD","BK4597"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2589876889","title":"Neurocrine Biosciences (NBIX) valuation update after NBI-1070770 Phase 2 trial failure reshapes pipeline expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2589876889","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589876889?lang=en_us&edition=fundamental","pubTime":"2025-12-07 14:11","pubTimestamp":1765087888,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) just shared a key clinical update, revealing that its investigational depression drug NBI-1070770 missed the primary efficacy endpoint in a Phase 2 trial, raising new questions about the company’s broader pipeline strategy.\nSee our latest analysis for Neurocrine Biosciences.\nDespite the setback, Neurocrine’s share price has held up reasonably well, with the stock at $155.51 and showing a 90 day share price return of 8.14 percent. Its 1 year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-valuation-update-after-nbi-10707","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-valuation-update-after-nbi-10707","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0154245756.USD","LU2065170008.USD","LU2065169927.USD","NBIX","BK4139","LU0823416689.USD","NBI","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","LU0154245673.USD","LU2065171402.SGD","LU2324357040.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583050978","title":"Press Release: National Bank Investments Announces November 2025 Cash Distributions for NBI ETFs and NBI Funds ETF Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2583050978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583050978?lang=en_us&edition=fundamental","pubTime":"2025-11-14 21:30","pubTimestamp":1763127000,"startTime":"0","endTime":"0","summary":"MONTREAL, Nov. 14, 2025 /CNW/ - National Bank Investments Inc.  announced today the November 2025 cash distribution amounts per unit for certain NBI Exchange-Traded Funds  and ETF Series of NBI Funds .Unitholders of record on November 21, 2025, will receive cash distributions on November 28, 2025, as detailed in the table below.NBI Global Real Assets Income ETF       NREA          $0.0500       Monthly. NBI Active Canadian Preferred Shares    NPRF          $0.1000       Monthly. NBI Unconstrained Fixed Income ETF      NUBF          $0.0800       Monthly. NBI Sustainable Canadian Bond ETF       NSCB          $0.0700       Monthly. NBI Sustainable Canadian Short Term     NSSB          $0.0260       Monthly. NBI Target 2026 Investment Grade Bond   NTGA          $0.0100       Monthly. NBI Target 2027 Investment Grade Bond   NTGB          $0.0130       Monthly. NBI Target 2029 Investment Grade Bond   NTGD          $0.0150       Monthly. National Bank Investments  Inc.  is an investment fund","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","TGT","BK4588","US5Y.BOND","LU1244550221.USD","LU0310800965.SGD","US10Y.BOND","LU1244550494.USD","LU0211328371.USD","LU0052756011.USD","LU1267930227.SGD","US3Y.BOND","BK4532","LU0823411888.USD","LU2237443978.SGD","BK4533","US2Y.BOND","NBI","US30Y.BOND","LU1244550577.SGD","BK4550","BK4596","US12M.BOND","TMF","FDN","LU0128525689.USD","NBHC","US6M.BOND","BK4585","TLTW","LU0310799852.SGD","US7Y.BOND","BK4504","LU2237443382.USD","LU2237443622.USD","BK4114","BK4597","BK4155","LU1267930490.SGD","BK4211","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2582388338","title":"Neurocrine says Phase 2 study of NBI-1070770 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388338?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:16","pubTimestamp":1762809366,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-107...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-says-phase-2-study-of-nbi-1070770-did-not-meet-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-says-phase-2-study-of-nbi-1070770-did-not-meet-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065170008.USD","LU2065171402.SGD","LU0320765992.SGD","LU2324357040.USD","NBIX","LU0154245673.USD","LU0889565916.HKD","LU2065169927.USD","LU0823416689.USD","BK4139","LU0154245756.USD","LU0109394709.USD","NBI","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579186605","title":"Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2579186605","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579186605?lang=en_us&edition=fundamental","pubTime":"2025-10-30 00:30","pubTimestamp":1761755429,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (($NBIX)) announced an update on their ongoing clinical study. Neurocrine Biosciences has recently completed a Phase 2 clini...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-completes-phase-2-study-on-nbi-1070770-for-depression?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurocrine-biosciences-completes-phase-2-study-on-nbi-1070770-for-depression?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154245673.USD","NBIX","LU0889565916.HKD","LU2065171402.SGD","LU2324357040.USD","LU2065170008.USD","LU0154245756.USD","LU2065169927.USD","NBI","LU0109394709.USD","BK4139","LU2065171311.SGD","LU0823416689.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.69697,"avgChangeRate":0.022961},{"month":2,"riseRate":0.515152,"avgChangeRate":0.004736},{"month":3,"riseRate":0.424242,"avgChangeRate":-0.016509},{"month":4,"riseRate":0.545455,"avgChangeRate":0.003143},{"month":5,"riseRate":0.5625,"avgChangeRate":0.015518},{"month":6,"riseRate":0.5625,"avgChangeRate":0.014583},{"month":7,"riseRate":0.65625,"avgChangeRate":0.027584},{"month":8,"riseRate":0.59375,"avgChangeRate":0.01258},{"month":9,"riseRate":0.4375,"avgChangeRate":0.005593},{"month":10,"riseRate":0.40625,"avgChangeRate":-0.002731},{"month":11,"riseRate":0.71875,"avgChangeRate":0.03022},{"month":12,"riseRate":0.575758,"avgChangeRate":0.023416}],"exchange":"NASDAQ","name":"NASDAQ Biotechnology","nameEN":"NASDAQ Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest NASDAQ Biotechnology(NBI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"NASDAQ Biotechnology,NBI,NASDAQ Biotechnology股票,NASDAQ Biotechnology股票老虎,NASDAQ Biotechnology股票老虎国际,NASDAQ Biotechnology行情,NASDAQ Biotechnology股票行情,NASDAQ Biotechnology股价,NASDAQ Biotechnology股市,NASDAQ Biotechnology股票价格,NASDAQ Biotechnology股票交易,NASDAQ Biotechnology股票购买,NASDAQ Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NASDAQ Biotechnology(NBI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest NASDAQ Biotechnology(NBI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction